Brief: Bicara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
14/08/2026 13:49
BRIEF-Bicara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) Aug 14 (Reuters) - Bicara Therapeutics Inc BCAX.O:
BICARA THERAPEUTICS ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
Source text: ID:nGNX9rxn1D
Further company coverage: BCAX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bicara Therapeutics
See all newsBrief: Bicara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Bicara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Bicara Therapeutics Appoints Ryan Cohlhepp As President & CEO Effective January 2027
Brief: Bicara Therapeutics Announces Appointments Of Jeremy Bender And Christy Oliger To Board Of Directors